THE LATEST WORD

Top Industry Stories – April 15, 2010

Posted on April 15th, 2010 | by Rxmedyn | No Comments »

U.S. Reforms To Hurt Non-profit Hospitals: Moody’s

Eisai Cuts Aricept Price, Joining Glaxo, Sanofi Race

A Pill That Can Tell If It’s Been Taken?

Preventing Childhood Obesity From Pregnancy On

Novartis Announces New Changes to US Pharma Biz

Read the rest of this entry »

Top Industry Stories – April 14, 2010

Posted on April 14th, 2010 | by Rxmedyn | No Comments »

U.S. Team Discovers New Alzheimer’s Risk Gene

Climate Change Could Raise Cost of U.S. Allergies

Obama Spurs Harvard Hiring While UnitedHealth Buys

Michelle Obama’s ‘Spotlight’ on Obesity Enlists Kraft, PepsiCo

An Insurer’s New Approach to Diabetes

Read the rest of this entry »

Top Industry Stories – April 13, 2010

Posted on April 13th, 2010 | by Rxmedyn | No Comments »

Cheap Antifungal Drug May Fight Cancer: Study

Groups Urge Drug Safety Steps With Industry Fees

Novartis Moves Closer To First Oral MS Treatment

Roche Shuns ‘Not Invented Here Syndrome’ to Boost Sales, Profit

CVS to Double In-Store Clinics After Health-Care Law

Read the rest of this entry »

Top Industry Stories – April 12, 2010

Posted on April 12th, 2010 | by Rxmedyn | No Comments »

Drug Label Accuracy Getting Lost In Translation

Merck Bucks Trend With Acquisition Loan as Borrowers Hoard Cash

Judge Approves $110M Settlement In E-Ferol Case

Health Care Overhaul May Help a Fund Sector

An Old Gout Drug Gets New Life and a New Price, Riling Patients

Read the rest of this entry »

Top Industry Stories – April 9, 2010

Posted on April 9th, 2010 | by Rxmedyn | No Comments »

Amylin, Lilly’s Byetta May Have Cancer Risk, FDA Says

Biogen Seeks Test for Brain Disease Linked to MS Drug

For Many, Health Law Offers a Chance for Preventive Care

Third-parties May Be Key To Social Media Cred, Says Survey

Sun To Sell Generic Wellbutrin, Plans Emerging Markets Push

Top Industry Stories – April 8, 2010

Posted on April 8th, 2010 | by Rxmedyn | No Comments »

Gene Found That May Predict Lung Cancer In Smokers

“Fat dissolving” Spa Treatment No Such Thing: FDA

Sphera Health Fund Shuns Teva Shares for ‘Cheap’ Pfizer, Sanofi

What Happened To All The Bad Blood Over Health Care?

New Drug Shows Promise For Curing Hepatitis C

Read the rest of this entry »

Top Industry Stories – April 7, 2010

Posted on April 7th, 2010 | by Rxmedyn | No Comments »

Teva Wins U.S. Approval For Generics Of Merck Drugs

Pfizer Sees ‘Golden Age’ In Alzheimer’s, Cancer Drugs

Sebelius Warns Of Health-Insurance Scam

Novartis Bias Suit To Begin

In Medicine, The Power Of No

Read the rest of this entry »

Top Industry Stories – April 6, 2010

Posted on April 6th, 2010 | by Rxmedyn | No Comments »

Pharma Seeks Genetic Clues To Healthy Ageing

Prescription Drug Overdoses On The Rise In U.S.

Judge Holds Off Accepting Boston Scientific Unit’s Guilty Plea

Reportlinker Adds Pharmaceutical Licensing Overview

Harder-to-Break OxyContin Pill Wins Approval

Read the rest of this entry »

Top Industry Stories- April 5, 2010

Posted on April 5th, 2010 | by Rxmedyn | No Comments »

SC Completes $12.7M Deal With Pfizer

Obama Health Gift to Guitarist Adds Adult Kids to Payrolls

New Health Initiatives Put Spotlight on Prevention

Generic Business Faces Tougher Slog

FDA Proposes Standard For Print, Broadcast Drug Ads

Top Industry Stories- April 2, 2010

Posted on April 2nd, 2010 | by Rxmedyn | No Comments »

Health Overhaul To Hit Corporate Profits

Pfizer Said To Settle Neurontin Suicide Lawsuit For $400,000

Health Care for All, With Obama Down the Street

Questions Arise Over Ketchum’s Health IT Contract

Medical Misinformation Can Spread Quickly Via ‘Tweets’

Read the rest of this entry »